In cancer cells, the overexpression of NRF2, resulting from constitutive activation or hyperactivation, facilitates their survival in environments rich in ROS, which is closely associated with enhanced proliferation and increased resistance to chemotherapy (179). This evidence concerns the gene NFE2L2 and cancer.